Vinva Investment Management Ltd

Position in INCY — Incyte Corp

CIK 1968109 SYDNEY, C3

Position in INCY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$52,467,882

+$24,193,764 QoQ

Shares Held

462,843

+54.1% QoQ

Ownership

0.232%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

#63

of 855 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Vinva Investment Management Ltd holds $143,806,233 across 13 Biotechnology names. INCY ranks #1 (36.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp This page	462,843	$52,467,882
2	ALNY	Alnylam Pharmaceuticals, Inc.	154,972	$46,651,221
3	REGN	Regeneron Pharmaceuticals, Inc.	34,494	$21,508,388
4	VRTX	Vertex Pharmaceuticals Inc / Ma	30,687	$15,243,153
5	HALO	Halozyme Therapeutics, Inc.	24,835	$1,943,835
6	EXEL	Exelixis, Inc.	31,102	$1,692,259
7	ASND	Ascendis Pharma A/S	4,536	$1,209,841
8	BMRN	Biomarin Pharmaceutical Inc	19,569	$1,119,738

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$52,467,882	462,843	+54.1%	Shares	Sole	2026-08-14
2026-03-31	$28,274,118	300,405	-31.1%	Shares	Sole	2026-05-14
2025-12-31	$43,063,028	435,993	+156.9%	Shares	Sole	2026-02-17
2025-09-30	$14,394,970	169,732	-14.5%	Shares	Sole	2025-11-13
2025-06-30	$13,511,380	198,405	+87.1%	Shares	Sole	2025-08-13
2025-03-31	$6,419,874	106,026	-5.6%	Shares	Sole	2025-05-14
2024-12-31	$7,753,729	112,259	+827.1%	Shares	Sole	2025-02-11
2024-09-30	$800,338	12,108	-70.1%	Shares	Sole	2024-11-14
2024-06-30	$2,455,473	40,506	-40.7%	Shares	Sole	2024-08-13
2024-03-31	$3,890,709	68,294	+515.8%	Shares	Sole	2024-05-13
2023-12-31	$696,403	11,091	-7.5%	Shares	Sole	2024-02-13
2023-09-30	$692,431	11,986	+120.0%	Shares	Sole	2023-11-13
2023-06-30	$339,075	5,447	-63.4%	Shares	Sole	2023-08-14
2023-03-31	$1,074,654	14,870	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.